久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/28 | 5,190 | 5,320 | 5,160 | 5,310 | +220 | +4.3% | 199,900 |
2020/05/27 | 5,080 | 5,130 | 5,060 | 5,090 | -20 | -0.4% | 111,900 |
2020/05/26 | 5,070 | 5,130 | 5,010 | 5,110 | +90 | +1.8% | 123,300 |
2020/05/25 | 4,995 | 5,050 | 4,965 | 5,020 | +85 | +1.7% | 70,400 |
2020/05/22 | 4,935 | 4,995 | 4,890 | 4,935 | +10 | +0.2% | 107,500 |
2020/05/21 | 5,080 | 5,080 | 4,910 | 4,925 | -175 | -3.4% | 167,200 |
2020/05/20 | 5,050 | 5,130 | 5,020 | 5,100 | +80 | +1.6% | 126,500 |
2020/05/19 | 5,030 | 5,070 | 4,975 | 5,020 | +90 | +1.8% | 88,000 |
2020/05/18 | 4,915 | 5,000 | 4,900 | 4,930 | +20 | +0.4% | 75,400 |
2020/05/15 | 4,865 | 4,980 | 4,865 | 4,910 | +40 | +0.8% | 167,500 |
2020/05/14 | 5,090 | 5,120 | 4,855 | 4,870 | -200 | -3.9% | 132,600 |
2020/05/13 | 5,060 | 5,090 | 5,010 | 5,070 | -10 | -0.2% | 75,300 |
2020/05/12 | 5,090 | 5,140 | 5,060 | 5,080 | +20 | +0.4% | 75,700 |
2020/05/11 | 5,090 | 5,190 | 5,010 | 5,060 | -20 | -0.4% | 101,900 |
2020/05/08 | 5,170 | 5,190 | 5,060 | 5,080 | -10 | -0.2% | 149,500 |
2020/05/07 | 5,100 | 5,120 | 5,030 | 5,090 | +60 | +1.2% | 150,200 |
2020/05/01 | 5,060 | 5,130 | 5,020 | 5,030 | -50 | -1% | 101,300 |
2020/04/30 | 5,270 | 5,280 | 5,070 | 5,080 | -90 | -1.7% | 201,400 |
2020/04/28 | 5,140 | 5,190 | 5,040 | 5,170 | +110 | +2.2% | 133,600 |
2020/04/27 | 4,975 | 5,060 | 4,960 | 5,060 | +120 | +2.4% | 146,200 |
2020/04/24 | 4,980 | 5,000 | 4,900 | 4,940 | -40 | -0.8% | 152,400 |
2020/04/23 | 4,945 | 5,010 | 4,880 | 4,980 | +45 | +0.9% | 105,300 |
2020/04/22 | 4,815 | 4,945 | 4,795 | 4,935 | +85 | +1.8% | 115,300 |
2020/04/21 | 4,875 | 4,925 | 4,830 | 4,850 | -80 | -1.6% | 171,000 |
2020/04/20 | 4,855 | 4,950 | 4,825 | 4,930 | -65 | -1.3% | 131,300 |
2020/04/17 | 5,090 | 5,160 | 4,965 | 4,995 | -5 | -0.1% | 148,000 |
2020/04/16 | 4,970 | 5,040 | 4,950 | 5,000 | -30 | -0.6% | 148,700 |
2020/04/15 | 4,940 | 5,060 | 4,910 | 5,030 | +75 | +1.5% | 176,100 |
2020/04/14 | 4,940 | 5,020 | 4,880 | 4,955 | +25 | +0.5% | 208,600 |
2020/04/13 | 4,750 | 4,965 | 4,685 | 4,930 | -60 | -1.2% | 237,400 |
2020/04/10 | 4,920 | 5,020 | 4,725 | 4,990 | +120 | +2.5% | 222,600 |
2020/04/09 | 5,000 | 5,020 | 4,755 | 4,870 | -140 | -2.8% | 129,000 |
2020/04/08 | 4,825 | 5,040 | 4,825 | 5,010 | +185 | +3.8% | 135,600 |
2020/04/07 | 4,775 | 4,855 | 4,670 | 4,825 | +120 | +2.6% | 165,800 |
2020/04/06 | 4,645 | 4,730 | 4,520 | 4,705 | +150 | +3.3% | 139,900 |
2020/04/03 | 4,555 | 4,770 | 4,505 | 4,555 | -35 | -0.8% | 146,100 |
2020/04/02 | 4,755 | 4,830 | 4,550 | 4,590 | -135 | -2.9% | 175,200 |
2020/04/01 | 4,980 | 5,050 | 4,695 | 4,725 | -315 | -6.3% | 199,300 |
2020/03/31 | 5,390 | 5,400 | 5,010 | 5,040 | -330 | -6.1% | 203,800 |
2020/03/30 | 5,200 | 5,380 | 5,080 | 5,370 | +150 | +2.9% | 221,400 |
2020/03/27 | 5,390 | 5,390 | 5,010 | 5,220 | +50 | +1% | 352,300 |
2020/03/26 | 4,965 | 5,210 | 4,855 | 5,170 | +195 | +3.9% | 259,600 |
2020/03/25 | 4,750 | 4,975 | 4,715 | 4,975 | +470 | +10.4% | 210,900 |
2020/03/24 | 4,960 | 5,020 | 4,440 | 4,505 | -190 | -4% | 232,100 |
2020/03/23 | 4,550 | 4,710 | 4,470 | 4,695 | +170 | +3.8% | 288,700 |
2020/03/19 | 4,555 | 4,660 | 4,470 | 4,525 | +180 | +4.1% | 431,200 |
2020/03/18 | 4,250 | 4,550 | 4,205 | 4,345 | +165 | +3.9% | 330,700 |
2020/03/17 | 3,805 | 4,225 | 3,775 | 4,180 | +270 | +6.9% | 322,700 |
2020/03/16 | 4,010 | 4,150 | 3,890 | 3,910 | -50 | -1.3% | 198,200 |
2020/03/13 | 3,870 | 4,045 | 3,725 | 3,960 | -190 | -4.6% | 256,800 |
1251~
1300
件表示中 / 3735件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 400,200円 | +5.8% | +1.2% | 3.00% | 13.27倍 | 1.06倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 206,800円 | +8.4% | +0.2% | 2.03% | 15.03倍 | 1.80倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 89,500円 | -11.0% | +206.6% | 0.00% | 8.89倍 | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 350,300円 | +3.8% | -19.9% | 3.88% | 11.38倍 | 0.87倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
日本新薬 | 313,300円 | +8.0% | -15.3% | 3.96% | 8.80倍 | 0.85倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム